Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10249 - 10256 of 12025 results

SHRM: FMLA Continues to Challenge Employers

July 24, 2014| Blog| Viewpoint

Charting the Future of Premium Subsidies under the Affordable Care Act: Halbig v. Burwell and King v. Burwell

July 24, 2014| Blog| Viewpoint

No news doesn’t mean it’s gone away: Timing Update for the EU Data Protection Regulation

July 24, 2014| Blog| Viewpoint

Honing in on the new rules for the transfer of personal data outside of the EEA

July 24, 2014| Blog| Viewpoint

USCIS Rolls Out Full-Scale Implementation of L-1 Site Visit Program: Employers of L-1 Transferees Should Now Set up Processes to Prepare for Such Visits

July 24, 2014| Advisory| Viewpoint

Update on Google Unauthorized Children’s In-App Purchase Class Action: THE SHOW MUST GO ON!

July 23, 2014| Blog| Viewpoint

ML Strategies Posts Weekly Health Care Update on July 21, 2014

July 22, 2014| Blog| Viewpoint

COPPA Update: FTC Provides More Flexibility on Obtaining Verifiable Parental Consent

July 22, 2014| Blog| Viewpoint

News & Press Releases

Amenities Draw Law Firm Mintz’s S.F. Office to 525 Market St.

July 15, 2025

San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.

Mintz Advises on Cogent Biosciences’ $230 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering

July 14, 2025

Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.

View all News and Press Releases